Full article: Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from
Remicade (infliximab) in patients with established rheumatic disease. Report of clinical …

… Kirsi Paalanen, MD Katja Rannio, MD Tuomas Rannio, MD Juha Asikainen, MD Pekka
Hannonen, MD, PhD Tuulikki Sokka, MD, PhD … NIKIPHOROU E, SJÖWALL C …

Objective. Efficacy of TNF inhibitors in the treatment of RA assessed in randomized controlled
trials (RCTs) may not be fully comparable to routine care owing to the stringent inclusion …

Objective We aimed to characterise the clinical and radiographical phenotype of calcium
pyrophosphate dihydrate deposition (CPPD) disease in patients initially diagnosed with …

The objective is to evaluate the incidence of seropositive rheumatoid arthritis (RA) over 40-year
period in Northern Savo, Finland. Data on new seropositive RA patients according to the …

Objective Selection of efficacious medications for rheumatoid arthritis (RA) has tremendously
increased over a decade including new costly biologic agents and inexpensive …

Background Seronegative rheumatoid arthritis is associated with a milder course of progression
compared to seropositive disease. However, long-term follow-up data of the clinical …

Objective Frequent monitoring of patients with early rheumatoid arthritis ( RA ) is required
for achieving good outcomes. This study was undertaken to investigate the influence of text …

Objective. We analyzed remission rates at 3 and 12 months in patients with rheumatoid arthritis
(RA) who were naive for disease-modifying antirheumatic drugs (DMARD) and who were …

… Kalevi Kaarela, MD, PhD Elisabet Lindqvist, MD, PhD Arja Häkkinen, PhD Hannu
Kautiainen, MS Pekka Hannonen, MD, PhD Tuomas Rannio Tuulikki Sokka, MD, PhD …